Prestige BioPharma Limited
KSE:950210.KS
13500 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 41,389.925 | 64,058.947 | 107,279.224 | 125,021.951 | 268,340.074 | 245,262.773 | 308,944.884 | 268,650.508 | 259,336.956 | 386,719.934 | 447,393.356 | 458,975.123 | 464,829.207 | 45,976.24 |
| Short Term Investments
| 201,751.037 | 187,936.327 | 181,629.639 | 176,390.48 | 27,552.002 | 28,095.577 | 27,117.756 | 34,619.069 | 32,972.277 | 10,428.433 | 2,801.171 | 377.683 | 30.601 | 2,422.781 |
| Cash and Short Term Investments
| 243,140.962 | 251,995.274 | 288,908.863 | 301,412.431 | 295,892.076 | 273,358.35 | 336,062.64 | 303,269.577 | 292,309.233 | 397,148.367 | 450,194.527 | 459,352.806 | 464,829.207 | 48,399.021 |
| Net Receivables
| 9,514.458 | 3,749.101 | 2,848.7 | 133.212 | 0 | 0 | 15.451 | 0 | 0 | 0 | 679.266 | 649.558 | 1,076.551 | 0 |
| Inventory
| 7,807.674 | 8,047.582 | 9,873.524 | 7,146.027 | 11,807.129 | 15,190.718 | 16,321.213 | 2,156.949 | 20,146.15 | 14,370.469 | 6,309.45 | -155.88 | 4,600.599 | 0 |
| Other Current Assets
| 3,027.261 | 2,849.886 | -0.001 | 21,369.003 | 3,905.202 | 3,303.159 | 4,251.85 | 6,139.104 | 11,642.568 | 7,004.524 | 3,436.201 | 90.4 | -3,252.238 | 1,412.358 |
| Total Current Assets
| 263,490.355 | 266,641.843 | 301,631.086 | 311,475.621 | 311,604.407 | 291,852.227 | 356,651.154 | 311,565.63 | 324,097.951 | 418,523.36 | 459,940.178 | 459,936.884 | 467,254.119 | 49,811.379 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 316,926.436 | 313,727.791 | 313,587.189 | 310,438.169 | 308,598.024 | 287,530.65 | 269,950.589 | 38,342.182 | 40,666 | 44,373.604 | 28,704.674 | 6,437.462 | 5,213.996 | 4,518.716 |
| Goodwill
| 10,451.254 | 9,998.268 | 10,440.001 | 10,191.578 | 10,117.535 | 9,834.294 | 27,960.916 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 117,675.672 | 110,416.32 | 113,339.097 | 108,719.695 | 104,673.816 | 97,816.098 | 104,631.723 | 65,312.308 | 56,562.712 | 122,905.356 | 119,636.077 | 109,022.985 | 105,150.429 | 95,010.695 |
| Goodwill and Intangible Assets
| 128,131.2 | 120,426.238 | 123,779.098 | 118,911.273 | 114,791.351 | 107,650.392 | 132,592.639 | 65,312.308 | 56,562.712 | 122,905.356 | 119,636.077 | 109,022.985 | 105,150.429 | 95,010.695 |
| Long Term Investments
| 1,795.539 | 803.164 | -180,799.412 | -175,615.339 | 22,593.596 | -26,608.809 | -25,591.41 | 40,090.999 | 106,754.942 | 34,847.86 | 16,476.254 | 23,780.857 | 19,792.019 | 6,912.887 |
| Tax Assets
| -117,679.946 | -110,427.97 | 181,629.639 | 0 | 51,876.533 | 28,095.577 | 27,117.756 | 0 | 32,972.277 | 10,428.433 | 2,801.171 | 3,559.912 | -19,792.019 | 2,422.781 |
| Other Non-Current Assets
| 117,627.571 | 110,287.816 | 0.001 | 176,390.48 | -48,565.618 | 9,238.722 | 9,011.135 | 44,502.11 | 16,065.731 | 17,964.571 | 11,391.122 | 1,428.321 | 21,646.393 | 1,421.628 |
| Total Non-Current Assets
| 446,800.8 | 434,817.038 | 438,196.515 | 430,124.583 | 449,293.886 | 405,906.532 | 413,080.709 | 188,247.599 | 253,021.662 | 230,519.824 | 179,009.298 | 144,229.537 | 132,010.818 | 110,286.707 |
| Total Assets
| 710,291.155 | 701,458.881 | 739,827.601 | 741,600.204 | 760,898.293 | 697,758.759 | 769,731.864 | 499,813.229 | 577,119.613 | 649,043.184 | 638,949.476 | 604,166.42 | 599,264.937 | 160,098.086 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 1,957.786 | 807.276 | 2,350.713 | 462.148 | 30,070.758 | 2,285.859 | 3,523.177 | 2,623.877 | 5,838.706 | 1,002.356 | 577.155 | -563.075 | -1,189.405 | 0 |
| Short Term Debt
| 44,617.025 | 40,561.183 | 37,083.782 | 32,857.077 | 2,634.683 | 2,453.55 | 2,692.128 | 1,593.383 | 1,626.772 | 1,707.076 | 1,821.197 | 4,199.42 | 646.738 | 443.835 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | -2.249 | 0 | 632.311 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 48,987.008 | 48,298.135 | 54,324.775 | 100,024.975 | 42,280.691 | 48,245.365 | 44,549.378 | 18,674.353 | 14,011.373 | 16,710.315 | 16,732.281 | 563.075 | 1,189.405 | 0 |
| Other Current Liabilities
| 46,203.051 | 46,284.256 | 48,780.471 | 1,543.852 | 4,349.72 | 3,383.818 | 3,831.06 | 18,902.52 | 16,906.838 | 37,839.99 | 13,659.354 | 9,847.059 | 10,662.853 | 8,032.981 |
| Total Current Liabilities
| 141,764.87 | 135,950.851 | 142,539.741 | 134,888.052 | 79,335.851 | 56,368.592 | 54,595.743 | 41,794.133 | 38,383.689 | 57,259.737 | 32,789.987 | 14,046.479 | 11,309.591 | 8,476.816 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 42,574.618 | 44,804.119 | 48,973.426 | 51,516.294 | 70,322.4 | 42,149.675 | 42,969.556 | 2,655.876 | 2,568.069 | 2,813.416 | 3,268.026 | 3,571.377 | 3,603.554 | 2,434.596 |
| Deferred Revenue Non-Current
| 792.642 | 964.351 | 0 | 1,592.722 | 42,189.423 | 22,621.079 | 24,671.55 | 25,427.363 | 31,875.673 | 10,138.046 | 9,726.185 | 11,587.909 | 10,886.193 | 11,387.215 |
| Deferred Tax Liabilities Non-Current
| 7,525.718 | 7,209.215 | 7,537.835 | 7,368.339 | 7,361.218 | 7,155.14 | 8,527.2 | 0 | -31,875.673 | -10,138.046 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1,680.832 | 1,576.632 | 1,639.374 | 0.001 | 1,642.999 | 0 | 70.697 | 0.001 | 31,842.804 | 10,110.331 | 0.001 | 0.001 | 0 | 0 |
| Total Non-Current Liabilities
| 52,573.809 | 54,554.317 | 58,150.635 | 60,477.356 | 121,516.04 | 71,925.894 | 76,239.003 | 28,083.24 | 34,410.873 | 12,923.747 | 12,994.212 | 15,159.287 | 14,489.747 | 13,821.811 |
| Total Liabilities
| 194,338.679 | 190,505.167 | 200,690.377 | 195,365.408 | 200,851.891 | 128,294.486 | 130,834.746 | 69,877.373 | 72,794.562 | 70,183.484 | 45,784.198 | 29,205.765 | 25,799.338 | 22,298.627 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 2,299.464 | 0 | 0 | 0 | 3,197.586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 707,760.036 | 677,083.797 | 706,998.003 | 690,174.731 | 685,443.186 | 666,254.141 | 754,313.455 | 679,712.759 | 636,550.552 | 623,249.653 | 622,934.216 | 594,071.79 | 595,745.814 | 152,779.419 |
| Retained Earnings
| -276,528.685 | -263,140.308 | -261,509.23 | -246,151.329 | -235,826.254 | -215,491.085 | -224,526.228 | -259,601.048 | -142,828.632 | -53,820.034 | -39,725.141 | -27,954.242 | -30,638.307 | -21,890.737 |
| Accumulated Other Comprehensive Income/Loss
| -2,221.5 | 745.352 | -2,299.464 | 6,511.115 | 7,800.978 | 99,443.658 | -3,197.586 | 9,865.938 | 10,614.075 | 9,455.932 | 9,948.636 | 8,812.979 | 8,345.189 | 0 |
| Other Total Stockholders Equity
| 7,622.61 | 7,190.958 | 5,171.881 | -23.964 | 11.681 | -89,485.342 | -3,206.748 | -41.793 | -10.944 | -25.851 | 7.567 | 30.128 | 12.903 | 6,910.777 |
| Total Shareholders Equity
| 436,632.461 | 421,879.799 | 450,660.654 | 450,510.553 | 457,429.591 | 460,721.372 | 526,580.479 | 429,935.856 | 504,325.051 | 578,859.7 | 593,165.278 | 574,960.655 | 573,465.599 | 137,799.459 |
| Total Equity
| 515,952.476 | 510,953.714 | 539,137.225 | 546,234.796 | 560,046.402 | 569,464.274 | 638,897.118 | 429,935.856 | 504,325.051 | 578,859.7 | 593,165.278 | 574,960.655 | 573,465.599 | 137,799.459 |
| Total Liabilities & Shareholders Equity
| 710,291.155 | 701,458.881 | 651,351.031 | 741,600.204 | 760,898.293 | 589,015.858 | 769,731.864 | 499,813.229 | 577,119.613 | 649,043.184 | 638,949.476 | 604,166.42 | 599,264.937 | 160,098.086 |